Search
TARCEVA 150 MG, Comprimé pelliculé
Details
| --- | Description |
|---|---|
| Pack | Boîte de 30 |
| Strength (Dosage) | 150 MG |
| Laboratory | ROCHE S.A |
| Ingredients | Erlotinib |
| Therapeutic class | Antinéoplasique, inhibiteur de la tyrosine kinase |
| ATC code | L01XE03 |
| PPH | $1,754.20 |
| PPV | $1,788.50 |
| Refundable | Yes |
| Refund base | $1,788.50 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Tarceva est indiqué dans le traitement de première ligne et d'entretien de patients souffrant de cancer du poumon non à petites cellules localement avancé ou métastatique (CBNPC) et présentant des mutations activatrices de l'EGFR. Tarceva est indiqué dans le traitement de patients souffrant de cancer du poumon non à petites cellules localement avancé ou métastatique, après échec d'au moins une chimiothérapie. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem